Navigation Links
European Society of Human Reproduction and Embryology Annual Meeting
Date:5/28/2010

Sunday 27 June Wednesday 30 June 2010
Fiera Roma
Via Portuense, 1645-1647
00148 Rome
Italy www.fieraroma.it

New research findings from fertility experts from Europe, the Americas, Asia & Australasia

  • Free registration for bona fide media presenting official press credentials all sessions open
  • Media centre with free computing, fax, international phone & internet facilities & IT support
  • English, Italian, Spanish, German, French, and Swedish speaking press office staff [NB: The official conference language is English, but press packs in Italian, French and Spanish will be available]

Reproductive medicine is one of today's most exciting scientific and clinical areas. Every month brings announcements of research developments, medical 'firsts', new rulings by regulatory bodies, or ethical controversies often sparking heated debate among practitioners in the field themselves, as well as ethicists, legislators, the media and the public. ESHRE 2010 provides the media with the opportunity to hear the latest research news and interview the experts. All sessions, including Sunday pre-congress discussions, are open to the media.

News briefings will be held:
11.45 hrs CEST Monday 28 June (English)
13.00 hrs CEST Monday 28 June (Italian)
10.00 hrs CEST Tuesday 29 June (English)
09.15 hrs CEST Wednesday 30 July (English)

Here are a few of the new results to be announced at the conference:

  • Researchers develop accurate way to predict the age when women will hit the menopause; the development could help young women plan when to start their families
  • Understanding the mechanism behind why some sub-fertile women respond poorly to ovarian stimulating hormones opens the way to designing personalised treatments
  • Mothers who drink alcohol while pregnant may be damaging the semen quality of their future sons
  • Cheap and simple, non-invasive blood test could replace invasive diagnostic techniques for detecting chromosomal abnormalities in early pregnancy
  • The rejuvenating effects of ovarian transplants: not only can they restore fertility, but could they also lengthen life?
  • In vitro maturation: do eggs matured in the laboratory result in babies with Large Offspring Syndrome?
  • New, non-surgical treatment for uterine fibroids can improve quality of life and maintain fertility
  • How do pregnancy rates from vitrified oocytes compare with those obtained from fresh eggs?
  • Two surveys throw light on why women choose egg freezing for social rather than medical reasons
  • How does being overweight affect women's chances of successful pregnancy through ART?
  • EU requirement for viral screening at each gamete donation is expensive and unnecessary, say Irish researchers
  • Endometriosis affects women's productivity at work more than other conditions causing pelvic pain
  • Latest figures on the use of ART in Europe and across the world

For further information about the media programme, please contact
Hanna Hanssen, ESHRE Communications Manager, on +32 (0) 2 269 0969, hanna@eshre.eu
or conference press officer Mary Rice on +33 (0)3 21825444; mary@mrcommunication.org

To register, download the form at:

http://www.eshre.eu/ESHRE/English/Annual-meeting/Rome-2010/For-the-media/First-media-alert/page.aspx/586

and fax or email it with a scanned copy of your press credentials before Wednesday 23 June to:

Hanna Hanssen
ESHRE Communications Manager
Fax: +32 (0) 2 269 56 00
Tel: +32 (0) 2 269 09 69
Email: hanna@eshre.eu

Registration in advance is recommended. You may register on site providing that you produce correct press credentials - an officially recognised press card and/or a commissioning letter from a recognised media organisation. Business cards are not acceptable.


'/>"/>

Contact: Mary Rice
mary@mrcommunication.org
European Society of Human Reproduction and Embryology
Source:Eurekalert

Related biology news :

1. European Alliance targets separation technologies for sustainable energy systems
2. Consumers in European countries appreciate grain healthiness in diverse ways
3. 2 Hopkins scientists awarded European honorary doctorates
4. 2nd European Lung Cancer Conference
5. First studies of fossil of new human ancestor take place at the European Synchrotron
6. Cold fronts linked to European H5N1 outbreaks
7. Rare cancers in the spotlight at major European conference
8. Finland invests €1.85 million in pan-European infrastructure for biomedical research
9. European Research Council grant for neuroscience research
10. 77 percent of European pigs are castrated without anesthetic
11. TGen Drug Development establishes European footprint
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/7/2017)... 7, 2017   MedNet Solutions , an innovative ... of clinical research, is pleased to announce that the ... innovative, highly flexible and award winning eClinical solution, is ... iMedNet is a proven Software-as-a-Service (SaaS) clinical research ... (EDC), but also delivers an entire suite of eClinical ...
(Date:2/6/2017)... Feb. 6, 2017 According to Acuity ... driving border authorities to continue to embrace biometric ... are 2143 Automated Border Control (ABC) eGates and ... at more than 163 ports of entry across ... 2016 achieving a combined CAGR of 37%. APC ...
(Date:2/2/2017)... 2, 2017   TapImmune, Inc. (NASDAQ: ... specializing in the development of innovative peptide and ... cancer and metastatic disease, announced today it has ... of a second clinical lot of TPIV 200, ... alpha. The manufactured vaccine product will be used ...
Breaking Biology News(10 mins):
(Date:2/24/2017)... 2017 Provectus Biopharmaceuticals, Inc. (OTCQB: PVCT, ... clinical-stage oncology and dermatology biopharmaceutical company, today is ... in its previously announced rights offering of up ... common stock and Series C Convertible Preferred Stock ... As previously announced, the rights ...
(Date:2/24/2017)... Feb. 24, 2017 China Cord Blood Corporation (NYSE: ... leading provider of cord blood collection, laboratory testing, hematopoietic ... announced its unaudited financial results for the third quarter ... December 31, 2016. Third Quarter of Fiscal ... quarter of fiscal 2017 increased by 18.6% to RMB200.9 ...
(Date:2/24/2017)... , Feb. 24, 2017  OncoSec Medical Incorporated ... immunotherapies, will host a Key Opinion Leader event to ... an oral and poster presentation at the upcoming 2017 ... The KOL event will be held in-person and via ... EST / 9:00 AM PST at the Lotte New ...
(Date:2/23/2017)... 2017 /PRNewswire/ - The Fight Against Cancer Innovation Trust ... are pleased to report that Fusion Pharmaceuticals Inc. (Fusion) ... & Johnson Innovation – JJDC, Inc. (JJDC) as the ... TPG Biotechnology Partners, and Genesys Capital, as well as ... ...
Breaking Biology Technology: